2021

Alcove-project

  • Home
  • Aims
    • Context
    • Means
    • Objectives
  • Partners
    • Member States
    • Workpackage Leaders
    • Associated Partners
    • Collaborating Partners
    • All Partners
  • 4 Core questions
    • Prevalence
    • Early diagnosis
    • Care & Services
    • Ethics & Dignity
  • Shared focus
    • Antipsychotics in dementia
    • Risk Exposure
    • Risk Reduction
  • ALCOVE in progress
    • Monitoring
    • Alcove methods
      • Alcove procedures
    • Glossary
  • Communication
    • Flyers and Posters
    • Slides
    • Pictures
    • Reports
    • Newsletters
    • Press Releases
  • News and Events
    • Alcove News
    • Dementia-related events
HomePartners Associated Partners

Associated Partners

16 Associated Partners (AP)
AP 1: Haute Autorité de Santé, France
AP 2: Fondation Roi Baudouin, Belgium.
AP 3: Terveyden ja Hyvinvoinnin Laitos, Finland
AP 4: Assistance Publique-Hôpitaux de Paris, Espace Ethique, France
AP 5: Institut Nationale de la Santé et de la Recherche Médicale, France
AP 6: Athens Association of Alzheimer's Disease and Related Disorders, Greece
AP 8: Instituto Superiore di Sanità, Italy
AP 9: Ministero della Salute, Italy
AP 10: Università degli Studi di Brescia, Italy
AP 11: Psihiatrijas un Narkolog'ijas Centrs, Latvia
AP 12: Lithuanian University of Health Sciences, Lithuania
AP 13: Slovenska Akademia Vied - Neuroimmunologicky Ustav Miniterstvo skolstva Slovenskej Republiky, Slovakia
AP 15: Instituto de Salud Carlos III, Spain
AP 16: Karolinska Institutet, Sweden
AP 17: Association for Dementia Studies and Department of Health, United Kingdom

No number 7, these numbers are referenced in the budget agreement

ALCOVE has received funding from the European Commission in the framework of the Public Health Programme.
Grant Agreement N°2010 22 01

logo eahc logo EU